PharmEasy Unlisted Share Description –

PharmEasy-parent API Holdings is India’s largest digital healthcare platform which operates an integrated, end-to-end business that aims to provide solutions for the healthcare needs of consumers across the following critical stages-

A. providing digital tools and information on illness and wellness
B. offering teleconsultation
C. offering diagnostics and radiology tests
D. delivering treatment protocols including products and devices

API Holdings has developed a custom-built technology platform designed to deliver benefits across the healthcare value chain through an interconnected network. The company collaborates closely with various stakeholders, including consumers, pharmaceutical companies, wholesalers, pharmacies, hospitals, doctors, clinics, and diagnostic labs. Its expanding presence across India, combined with a connected ecosystem approach and diverse synergistic offerings, has allowed API Holdings to foster strong relationships throughout the healthcare value chain, encompassing wholesalers, chemists, consultants, consumers, and other enterprises.

What is PharmEasy?

PharmEasy is a comprehensive consumer healthcare “super app” that offers users on-demand, home-delivered access to a diverse array of prescription medications, over-the-counter (OTC) pharmaceuticals, and other healthcare products. In addition to these offerings, PharmEasy provides extensive diagnostic testing services and teleconsultations, effectively addressing various healthcare needs for its consumers.

Read Also: Sterlite Power Unlisted Shares

Products & Services of the PharmEasy

• Prescription Medications
• Over-the-counter (OTC) Products
• Diagnostic Services
• Teleconsultations
• Health Packages
• Home Delivery
• User-Friendly Mobile App

PharmEasy Subsidiaries Companies

• API Holdings Limited (Holding Company)
• Threpsi Solutions Private Ltd.
• AKP Healthcare Private Ltd.
• Eastern Agencies Healthcare Private Ltd.
• Venkatesh Medico Private Ltd.
• Aushad Pharma Distributors Private Limited
• Avighna Medicare Private Limited
• Aycon Graph Connect Private Limited
• Aryan Wellness Private Limited
• Ayro Retail Solutions Private Ltd.
• D.C Agencies Private Limited
• Mahaveer MediSales Private Limited
• Docon Technologies Private Ltd.
• Ascent Wellness and Pharma Solutions Private Ltd.
• Reenav Pharma Private Limited
• AHWSPL India Private Limited
• Thyrocare Technologies Limited
• Akna Medical Private Limited

Key Highlights –

• The company is expanding its product business in Semi Urban + Rural markets across India.
• PharmEasy’s revenue from operations declined by 14.75%, dropping to INR 5,664.2 crore in FY 2024, compared to INR 6,643.9 crore in FY 2023.
• PharmEasy’s total expenditure decreased by 19.16%, falling to INR 7,254.8 crore in FY 2024 from INR 8,974 crore in FY 2023.
• Deeper penetration into Tier-2 & Tier 3 cities
• In FY 2024, PharmEasy generated INR 5,008 crore from the sale of medicines, while revenue from lab tests and other services amounted to INR 652 crore.

Read Also: Biggest Unlisted Companies in India

API Holdings Board of Directors

• Mr. Siddharth Shah, MD & CEO
• Dr. Dhaval Shah, Whole-time Director
• Mr. Hardik Dedhia, Whole-time Director
• Mr. Shyam Powar, Non-Executive Director
• Dr. Ranjan Pai, Non-Executive Director
• Mr. Dovaldas Buzinskas, Non-Executive Director
• Mr. Aditya Puri, Chairman, Non-Executive Director
• Mr. Deepak Vaidya, Independent, Non-Executive Director
• Mr. Ankur Thadani, Non-Executive Director
• Mr. Ashutosh Sharma, Non-Executive Director
• Ms. Vineeta Rai, Independent, Non-Executive Director
• Dr. Jaydeep Tank, Independent, Non-Executive Director
• Mr. Subramaniam Somasundaram, Independent, Non-Executive Director

PharmEasy Unlisted Share Details

Name	PharmEasy Unlisted Share Details
Face Value	INR 1 per share
ISIN Code	INE0DJ201029
Lot Size	1,000 shares
Demat Status	NSDL, CDSL
API Holdings Unlisted Share Price	INR 8.40 per share
Market Cap	INR 5,242 crore
Total number of shares	6,24,04,35,432 shares
Website	www.pharmeasy.in

PharmEasy Unlisted Share Details – Shareholding Pattern

Details of shareholders holding more than 5% of a class of equity shares in the company:

Shareholder Name	% to Holding	No. of shares
Naspers Ventures B. V.	13.03	81,33,16,570
MacRitchie Investments Pte. Ltd.	11.74	73,25,16,290
TPG Growth V SF Markets Pte. Ltd	7.20	44,94,92,340
Evermed Holdings Pte. Ltd.	6.35	39,60,33,000
Prasid Uno Family Trust through its trustee Surbhi Singh	4.39	27,39,83,731
Others	57.29	3,57,50,93,501

PharmEasy Unlisted Share Details – Financial Metrics

Particulars	FY 2022	FY 2023	FY 2024
Revenue	5,728.82	6,643.94	5,664.29
Expenses	8,491.59	8,974.01	7,254.80
Net income	(3,992.50)	(5,211.73)	(2,533.51)
Margin (%)	(69.69)	(78.44)	(44.73)
ROCE (%)	–	(92.0)	(29.0)
EBITDA (%)	(40.18)	(23.40)	(11.41)
EPS	(7.28)	(8.51)	(4.07)
Debt / Equity	–	0.01	0.60

Read Also: Best IPOs That Doubled Investors’ Money

PharmEasy Annual Reports

PharmEasy Annual Report FY 2023 – 2024

PharmEasy Annual Report FY 2021 – 2022

PharmEasy Draft Red Herring Prospectus

PharmEasy Unlisted Share Peer Comparison

Company	3-yr Sales CAGR (%)	ROCE (%)	Net Margin (%)	MCap (INR crore)
PharmEasy (API Holdings)	34.36	(29.0)	(44.73)	5,242
Apollo Hospitals (Apollo Pharmacy)	21.8	15.1	4.91	1,02,451

PharmEasy Unlisted Share FAQs